Puma Biotechnology, Inc.Analytics - Traffic, Statistics and Competitor tracking | WatchMyCompetitor


Puma Biotechnology, Inc. Website Screenshot

http://www.pumabiotechnology.com

Puma Biotechnology, Inc. Company Intro

Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of cancer. Cougar was acquired by Johnson & Johnson in July 2009 for approximately $1 billion.

Industry

Healthcare

Puma Biotechnology, Inc. Headquaters

10880 Wilshire Boulevard
Los Angeles,90024
United States


Puma Biotechnology, Inc. Share price

14 Sep 2022 09:59 GMT

$2.6000

-0.11 (-4.06 %)


Puma Biotechnology, Inc. Market cap

$112.435 M


WMC RANKING

2022

Puma Biotechnology, Inc. # 31

Biotechnology

Latest Puma Biotechnology, Inc. News

News 24 Sep 2022

Head-To-Head Analysis: Puma Biotechnology (NASDAQ:PBYI ...

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of...

News 23 Sep 2022

PM360 Magazine Announces Winners of 2022 Trailblazer ...

COMPANY OF THE YEAR: PHARMACEUTICAL/BIOTECH Amgen. Advertisement ... Women's Health: Heather Blaber, Vice President of Marketing, Puma Biotechnology, Inc.

News 23 Sep 2022

Takeda offloads cancer drug to Puma

Securo Bio's Copiktra looks on track to follow other PI3K inhibitors in bowing out of certain blood cancer markets after an FDA expert panel backed a negative...


WMC Market Score


WMC Market to Revenue Score


Puma Biotechnology, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Puma Biotechnology, Inc. USD $272,062 $208,212 $-26,534 $1,124M 31
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $754,300B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $713,610B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,520B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Puma Biotechnology, Inc. Social Followers vs Top 4 Industry Competitors



Puma Biotechnology, Inc. Post vs Top 4 Industry Competitors




Puma Biotechnology, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Puma Biotechnology, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Puma Biotechnology, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Puma Biotechnology, Inc. 2.96 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries